These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39428290)

  • 1. Trends and Regional Differences for Fertility Preservation Procedures in Women With Breast Cancer.
    Turan V; Bedoschi G; Lee DY; Barbosa CP; de Oliveira R; Sacinti KG; Sonmezer M; Lambertini M; Massarotti C; Schaub A; Wang E; Gayete-Lafuente S; Dunlop C; Anderson RA; Bang H; Oktay KH
    Clin Breast Cancer; 2024 Sep; ():. PubMed ID: 39428290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
    Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
    Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
    Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
    J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
    Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
    Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Experience of Fertility Preservation in a Single Tertiary Center in Korea.
    Choi YJ; Hong YH; Kim S; Kim SK; Lee JR; Suh CS
    Front Endocrinol (Lausanne); 2022; 13():845051. PubMed ID: 35518927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
    Alvarez RM; Ramanathan P
    Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of early referral to fertility preservation in young women with breast cancer.
    Lee S; Ozkavukcu S; Heytens E; Moy F; Oktay K
    J Clin Oncol; 2010 Nov; 28(31):4683-6. PubMed ID: 20876425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
    Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
    Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
    Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Walking the tightrope: Fertility preservation among hereditary breast and ovarian Cancer syndrome Previvors.
    Holtzman S; McCarthy L; Estevez SL; Lee JA; Baird MF; Gounko D; Copperman AB; Blank SV
    Gynecol Oncol; 2024 Jul; 186():176-181. PubMed ID: 38696905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
    Martinez F
    Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
    Martinez F;
    Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective and Onco-fertility preservation: factors related to IVF outcomes.
    Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
    Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility preservation for cancer patients: treatment gaps and considerations in patients' choices.
    Kappy M; Lieman HJ; Pollack S; Buyuk E
    Arch Gynecol Obstet; 2021 Jun; 303(6):1617-1623. PubMed ID: 33544203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
    Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
    Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up.
    Dezellus A; Mirallie S; Leperlier F; Sauterey B; Bouet PE; Dessaint A; Duros S; Gremeau AS; Mouret-Reynier MA; Durand LM; Venat L; De Blay P; Robert M; Freour T; Campone M; Blanc-Lapierre A; Bordes V
    Breast; 2024 Oct; 77():103776. PubMed ID: 39167853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of young women with breast cancer to identify rates of fertility preservation (FP) discussion and barriers to FP care.
    Sauerbrun-Cutler MT; Pandya S; Recabo O; Raker C; Clark MA; Robison K
    J Assist Reprod Genet; 2023 Aug; 40(8):2003-2011. PubMed ID: 37329421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.